Oncotelic Therapeutics, Inc. Gain (Loss) on Investments
Oncotelic Therapeutics, Inc. (OTLC) reported Gain (Loss) on Investments of $365.35 million for the 12-month period ending 2025-12-31, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2026-08-13
- Oncotelic Therapeutics, Inc. gain (loss) on investments for fiscal 2023 was $12.71K.
| Period end | Gain (Loss) on Investments 12 month |
|---|---|
| 2025-12-31 | $365.35M 10-Q · filed 2026-08-13 |
| 2023-12-31 | $12.71K 10-K · filed 2025-04-15 |